6 completed. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 6 |
Follow Bladder Cancer: new trials by email Literature Review of Bladder Cancer trials Research Report on Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC Mitomycin c - Bladder Cancer | Phase 4 | Completed | Jørgen Bjerggaard Jensen | 120 | 2017-11-01 | 2026-03-03 |
| Investigation of Sugammadex in Outpatient Urological Procedures Rocuronium, Sugammadex, Neostigmine - Malignant Neoplasms of Urinary Tract, Bladder Cancer | Phase 4 | Completed | M.D. Anderson Cancer Center | 54 | 2017-09-18 | 2020-09-22 |
| Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders Coloverin, Placebo - Oncology, Incontinence | Phase 4 | Completed | Mansoura University | 110 | 2017-05-15 | 2020-06-30 |
| Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking smoking cessation intervention, bupropion hydrochloride, gene expression analysis - Bladder Cancer, Cervical Cancer | Phase 4 | Completed | Lisa Sanderson Cox, PhD | 540 | 2007-12-01 | 2017-11-13 |
| In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? Intravesical BCG instillation - Bladder Cancer, Disease Progression | Phase 4 | Completed | Ankara Training and Research Hospital | 400 | 2007-01-01 | 2017-06-05 |
| Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking nicotine lozenge, nicotine patch - Bladder Cancer, Cervical Cancer | Phase 4 | Completed | Fox Chase Cancer Center | 642 | 2006-02-01 | 2016-03-29 |
Urinary Bladder Neoplasms (6) · Carcinoma, Hepatocellular (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2) · Esophageal Neoplasms (2) · Head and Neck Neoplasms (2) · Hypopharyngeal Neoplasms (2) · Kidney Neoplasms (2) · Laryngeal Neoplasms (2) · Leukemia (2) · Leukemia, Myeloid, Acute (2) · Liver Neoplasms (2) · Lung Neoplasms (2) · Mouth Neoplasms (2) · Nasopharyngeal Neoplasms (2)
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Male Urogenital Diseases (6) · Neoplasms by Site (6) · Urinary Bladder Diseases (6) · Urogenital Diseases (6) · Urogenital Neoplasms (6) · Urologic Diseases (6) · Neoplasms (5) · Urologic Neoplasms (5) · Mental Disorders (3) · Adenocarcinoma (2) · Bronchial Neoplasms (2) · Carcinoma (2) · Carcinoma, Bronchogenic (2)
Bupropion (1) · Counseling (1) · Early Intervention, Educational (1) · Gene Expression Profiling (1) · Glycopyrrolate (1) · Mitomycin (1) · Neostigmine (1) · Polymerase Chain Reaction (1) · Psychiatric Rehabilitation (1) · Rocuronium (1) · Sugammadex (1) · Tobacco Use Cessation Devices (1) · mebeverine (1)
Ankara Training and Research Hospital (1) · Fox Chase Cancer Center (1) · Jørgen Bjerggaard Jensen (1) · Lisa Sanderson Cox, PhD (1) · M.D. Anderson Cancer Center (1) · Mansoura University (1)
United States (3) · Denmark (1) · Egypt (1)
Ahmed Elhussein, MBBCH (1) · Ahmed Elkarta, MBBCH (1) · Ahmed Mosbah, MD (1) · Farzin Goravanchi, DO (1) · Hassan Abol-Enein, MD (1) · Lisa S. Cox, PhD (1) · Mohamed Soltan, MBBCH (1) · Robert A. Schnoll, PhD (1)
PMID 21266057, PMID 21775497, PMID 22241828, PMID 23733379, PMID 23759377, PMID 23982601, PMID 33300144, PMID 34611902, PMID 34791718, PMID 36223555, PMID 37230961, PMID 39868569
R01CA091912 (1)